ClinicalTrials.gg
CompletedNCT00463307Updated Oct 31, 2007

Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in Kenya

An observational study in Schistosomiasis Mansoni and Circulating Cathodic Antigen Urine Based Dipstick, sponsored by DBL -Institute for Health Research and Development. Completed at 1 site in Kenya. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2007-10-31.

Sponsored by DBL -Institute for Health Research and Development · Observational

Study type
Observational
Enrollment
1,100
Ages
10 Years to 18 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the use of a urine test strip in diagnose schistosoma mansoni in areas of Kenya where the rate of infections are low.

The hypothesis is that the urine strip test is a superior tool to the conventional parasitological tools used to diagnose schistosomiasis mansoni infections in area where there is low transmission

Read the detailed description

The study will compare the use of the urine test strip with the conventional method used and with a "golden standard" methode, in an area of Kenya where the infection transmission is low. Furthermore will the urine test strip be evaluatied in its ability to monitor the intensity of infections in school children before and after they are been treated for the infections.

A total of 1100 school children in the age between 10 and 18 years will be included in the study. Children have to submitt a stool and a urine sample on three consecutive days. Children who are found to be infected with the schistosomiasis parasite will be offered treatment.

02

Conditions studied

  • Schistosomiasis Mansoni
  • Circulating Cathodic Antigen Urine Based Dipstick

Browse trials for

Keywords

  • schistosomiasis
  • Schistosoma mansoni
  • Circulating cathodic antigen urine dipstick
03

In context

Schistosomiasis

86 studies on the registry are indexed under Schistosomiasis; 15 are open to participants now.

This study's enrollment of 1,100 is above the median of 516 across 30 observational studies indexed under Schistosomiasis.

Browse Schistosomiasis studies →

Lead sponsor

DBL -Institute for Health Research and Development is the lead sponsor of 21 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children in the age between 10 and 18 years

Exclusion criteria

Exclusion Criteria:

  • Children younger then 10 years of age and children whos parent/guardians did not give informed consents for their participation in the study
05

Study design

Enrollment
1,100 participants (actual)
06

Study locations

1 site
  • Kenya Medical Research Institute
    Nairobi, Kenya
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 31, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00463307
Lead sponsor
DBL -Institute for Health Research and Development
First posted
Apr 20, 2007
Start date
Apr 2006
Completion
Nov 2006
Last update
Oct 31, 2007

Study contacts

Hussein J Kihara, mr
principal investigator · Division of Vector Borne Diseases, Kenya

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion